Oncology Digital Drug Delivery Systems Market Research Report - Segmented by Drug Type (Injected Drug, Oral Drug, Implanted Drug, Wearable Drug, and others); By Cancer Type (Lung Cancer, Kidney Cancer, Brain Cancer, Blood Cancer, Leukemia Cancer and Breast Cancer ); By End-User (Hospital, Clinics, and Research Institutes); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15531
Format:
Region: Global
Chapter 1. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - By Drug Type
6.1 Injected Drug
6.2 Oral Drug
6.3 Implanted Drug
6.4 Wearable Drug
6.5 Others
Chapter 7. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - By Cancer Type
7.1 Lung Cancer
7.2 Kidney Cancer
7.3 Brain Cancer
7.4 Blood Cancer
7.5 Leukemia Cancer
7.6 Breast Cancer
7.7 Others
Chapter 8. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET - By End-User
8.1 Hospital
8.2 Clinics
8.3 Research Institutes
Chapter 9. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET – By Region
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Latin America
9.5 The Middle East
9.6 Africa
Chapter 10. ONCOLOGY DIGITAL DRUG DELIVERY SYSTEMS MARKET – Key Players
10.1 F. Hoffmann-La Roche Ltd
10.2 Novartis AG
10.3 Johnson & Johnson
10.4 Pfizer Inc.
10.5 Merck & Co., Inc.
10.6 Bristol-Myers Squibb Company
10.7 AstraZeneca PLC
10.8 GlaxoSmithKline PLC
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
Advancements in digital health technologies, increased cancer prevalence, and the demand for accurate medication administration are key drivers of the Oncology Digital Drug Delivery Systems Market.
The integration of digital technologies in drug delivery systems enhances cancer treatment outcomes by enabling precise and targeted delivery of medications, real-time monitoring, and personalized patient care.
The Asia-Pacific region is poised to experience the highest growth in the Oncology Digital Drug Delivery Systems Market during the forecast period.
The market size in the year 2022 is $ 10.2 Billion.
The use of digital drug delivery systems in oncology research institutions contributes to advancements in cancer studies and drug development by enabling precise and targeted drug delivery trials on cancer cells and tumors, leading to valuable insights for future therapeutic options.
